Boston Scientific Corporation beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.83 | $0.86 | +3.6% | Beat |
| Q12026 FY2026 | $0.80 | $0.80 | +0.0% | Beat |
| Q42025 FY2025 | $0.78 | $0.80 | +2.6% | Beat |
Back to BSX overview · BSX holders · BSX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.